Familial adenomatous polyposis medical therapy: Difference between revisions

Jump to navigation Jump to search
(Mahshid)
Line 19: Line 19:
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Gastroenterology]]

Revision as of 23:24, 26 November 2017

Familial adenomatous polyposis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Familial adenomatous polyposis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Familial adenomatous polyposis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Familial adenomatous polyposis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Familial adenomatous polyposis medical therapy

CDC on Familial adenomatous polyposis medical therapy

Familial adenomatous polyposis medical therapy in the news

Blogs on Familial adenomatous polyposis medical therapy

Directions to Hospitals Treating Familial adenomatous polyposis

Risk calculators and risk factors for Familial adenomatous polyposis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]

Overview

Non-steroidal anti-inflammatory drugs (NSAIDs) maybe helpful in the treatment of familial adenomatous polyposis.

Medical Therapy

Various medications are being investigated for slowing malignant transormation of polyps, most prominently the non-steroidal anti-inflammatory drugs (NSAIDs). The NSAIDs have been shown to significantly decrease the number of polyps. Due to the high number of polyps, NSAIDs does not alter the management and the mainstay of treatment is surgery.

References

Template:WH Template:WS